Researchers propose new target, repurposed drugs to make CAR T-cell therapy safer

CAR T-cell therapy has transformed crab care, offering caller anticipation to patients with assertive humor cancers who erstwhile had fewer attraction options. But for immoderate patients, the almighty immunotherapy tin trigger a perchance life-threatening complication that causes encephalon inflammation, confusion, seizures and different superior neurological symptoms.